T1	p 246 291	patients with asthma poorly controlled on low
T2	p 691 709	adult asthmatics .
T3	p 718 736	Sixty-six subjects
T4	i 6 44	Salmeterol plus fluticasone propionate
T5	i 52 91	fluticasone propionate plus montelukast
T6	i 433 451	placebo-controlled
T7	i 504 560	salmeterol plus fluticasone propionate ( FP ) ( Seretide
T8	i 573 601	FP plus montelukast ( FP/M )
T9	o 153 172	airway inflammation
T10	o 605 687	sputum inflammatory markers , airway responsiveness , lung function , and symptoms
T11	o 818 896	neutrophil , eosinophil , macrophage , lymphocyte , and epithelial cell levels
T12	o 908 916	sputum .
T13	o 950 1067	change in other sputum markers of airway inflammation , airway responsiveness , symptom control , and lung function .
T14	o 1129 1154	sputum inflammatory cells
T15	o 1203 1223	sputum eosinophils .
T16	o 1263 1284	airway responsiveness
T17	o 1340 1373	symptom control and lung function
T18	o 1434 1440	sputum